Tanzania
+918770708752

Abirakast 250 Options from a Pharmaceutical Exporter in Dodoma

A quote for Abirakast 250 is not enough to establish that you are receiving the right abiraterone product, in the right strength, with usable regulatory documents and shelf life. By the end, you will know how to identify the formulation, assess safe-use requirements, compare suppliers, and specify an export order that your destination’s healthcare system can legally receive.

Key takeaways

  • Confirm the manufacturer, marketing authorisation number and abiraterone acetate salt.
  • Match the 250 mg tablet to the prescriber’s treatment plan.
  • Request batch, expiry, storage and product-information documents before ordering.
  • Specify destination rules, pack details and shipping documents in the purchase order.

What Abirakast 250 must be before you compare offers

Confirm the quoted product against its approved identity before comparing price. “Abirakast 250” should mean a registered brand of immediate-release abiraterone acetate 250 mg tablets, not simply any abiraterone product. Ask for the exact manufacturer, marketing authorisation number, active-ingredient salt, dosage form, and approved product information.

CheckAcceptable evidenceWhat it rules out
Product identityAbiraterone acetate 250 mg tablet named in the approved specificationAnother salt, strength, or similarly named oncology medicine
Market approvalProduct-specific approval number and current certificateA generic claim such as “EU/FDA approved”
Batch identityBatch number, manufacturing date, expiry date, certificate of analysis, and batch-release record matching the shipmentDocuments belonging to another batch
Quality statusApplicable GMP evidence and bioequivalence or required quality documentation for the exact marketed productReliance on the manufacturer’s reputation alone

An abirakast 250 pharmaceutical exporter in dodoma should also identify the authorised Tanzanian importer or consignee and provide documents required for the current Tanzania Medicines and Medical Devices Authority process. Confirm the TMDA import permit procedure before payment; freight arrangements do not replace regulatory approval.

Place the approved wording in the purchase order: “abiraterone acetate 250 mg immediate-release tablets,” followed by the brand, manufacturer, pack size, batch-document requirements, and storage conditions. Do not accept a quotation that identifies only “abiraterone 250” or supplies certificates for a different product.

The administration and safety conditions that affect the order

Abiraterone acetate is prescription-only oncology treatment; an oncologist or urologist must select it, prescribe the accompanying corticosteroid, and assess whether androgen suppression is appropriate. Abiraterone inhibits CYP17, reducing androgen production that can drive prostate-cancer growth. It is not a cosmetic, wellness, or over-the-counter product.

Before accepting a quotation, confirm that the exact immediate-release abiraterone acetate 250 mg tablet has current approval and product information. Ask the abiraterone tablet exporter for:

  1. The approved active-ingredient wording, strength, dosage form, manufacturer, marketing-authorisation number, and current certificate for the quoted brand.
  2. The prescribed dose: four 250 mg tablets once daily, equalling 1,000 mg abiraterone acetate, unless the treating specialist changes it.
  3. Written administration instructions: take tablets on an empty stomach at least 1 hour before or 2 hours after food, swallow them whole, and do not crush, chew, or split them. Food can sharply increase exposure and toxicity.
  4. Monitoring requirements for blood pressure, serum potassium, fluid retention or oedema, and liver tests including transaminases and bilirubin. The prescriber must act on abnormal results.
  5. Handling precautions stating that pregnant women or women who may become pregnant must not handle damaged or crushed tablets without protective precautions because abiraterone can harm a fetus.
  6. Storage and transport instructions from the approved label, plus batch traceability and a recall contact.

Do not treat an “EU/FDA approved” claim as proof for this product. The authorisation number and matching quality documents matter.

When 250 mg tablets fit the treatment plan—and when they do not

A 250 mg tablet fits only when the prescriber has selected abiraterone acetate in that strength; it does not mean the daily treatment is 250 mg. A common regimen uses four 250 mg tablets to provide 1,000 mg once daily, but follow the prescribed dose rather than converting tablet counts yourself.

Quoted itemWhat to confirmPurchasing decision
Abirakast 250Abiraterone acetate, immediate-release tablet, 250 mg; same manufacturer and marketing authorisation numberCompare only with products matching these details
500 mg abiraterone tabletSame active ingredient but a different tablet strength and count per doseDo not substitute without prescriber approval
125 mg or food-effect formulationDifferent strength, formulation, or administration conditionTreat as a separate product
Compounded or unnamed abirateroneProduct identity, approval status, and quality controls may differDo not treat it as an equivalent offer

The approved product information must state the administration condition. Patients take standard 250 mg abiraterone acetate tablets on an empty stomach, at least one hour before or two hours after food, swallowing them whole rather than crushing or chewing them. Food is not a convenient way to adjust the dose.

Reject a quotation when:

  • The seller cannot identify the exact product approval and current product information.
  • “Bulk” omits pack size, carton quantity, shelf life, or storage conditions.
  • The offer quietly changes the salt, strength, formulation, or brand after comparison.
  • The buyer lacks a prescription and oncology oversight for the intended market.

How to test an abiraterone exporter before requesting bulk supply

A credible Abirakast 250 exporter proves the exact marketed product, not merely the manufacturer’s reputation. Match Abirakast 250 to its manufacturer, marketing authorisation number, abiraterone acetate salt, 250 mg strength, tablet form, and current approved product information. “EU approved” or “FDA approved” without an approval number and current certificate is not enough.

CheckEvidence to requestReject the supplier when
Supplier identityLegal company name, manufacturing site, applicable GMP certificate, and authorised contactThe certificate names a different site or has expired
Exact product qualityProduct-specific approval, bioequivalence or required quality documentation, approved product informationEvidence covers another abiraterone brand or strength
Batch statusCertificate of analysis, batch-release document, batch number, manufacturing date, expiry date, and storage conditionsDocuments are generic, incomplete, or do not match the proposed batch
TraceabilityBatch number linking the carton, blister, CoA, release record, and shipment invoiceThe exporter cannot trace the batch back to the released stock

Before requesting Abirakast 250 bulk supply, ask for scanned documents and compare every batch number with photographs of the packed goods. Confirm pack size, packs per carton, minimum order quantity, remaining shelf life at dispatch, temperature and humidity limits, shipping lane, and whether the price is EXW, FOB, CIF, or delivered to Tanzania.

NIBA HEALTHCARE should face the same test: request batch-specific evidence rather than relying on a catalogue listing or corporate certificate. If an Abirakast 250 international supplier refuses these records, choose another source before paying a deposit.

Related products

Abirakast 250

ABIRATERONE TABLET

Abirakast 250

Abirakast 250mg Tablet is used in the treatment of cancer of the prostate gland.

View product →
ABIRAKAST 250MG

ABIRATERONE TABLET

ABIRAKAST 250MG

Tablet is used in the treatment of cancer of the prostate gland. It may be also used to treat other conditions, as determined by the doctor.

View product →

What an export order must specify for lawful delivery to Tanzania or another market

A usable shipment begins with an order that fixes quantity, regulatory responsibility, transport risk, and receiving conditions—not merely a tablet price. An abirakast 250 bulk supply quotation must state tablets per pack, packs per carton, minimum order quantity, remaining shelf life at dispatch, and the exact shipping lane.

Price termSeller’s delivery pointBuyer must arrange
EXWSeller’s premisesCollection, export clearance, freight, insurance, and import clearance
FOBNamed port after vessel loadingMain freight, insurance, import clearance, and inland delivery
CIFNamed destination port with freight and insuranceImport clearance, taxes, port charges, and delivery
Delivered to TanzaniaNamed consignee addressConfirm who pays duties, permits, unloading, and last-mile delivery

Put these details in the purchase order:

  • Copy the approved wording: abiraterone acetate, immediate-release tablets, 250 mg; include manufacturer, marketing authorisation number, and registered brand name.
  • Name the authorised Tanzanian importer or consignee and confirm the current Tanzania Medicines and Medical Devices Authority (TMDA) import-permit procedure before payment.
  • Require the commercial invoice, packing list, import permit, certificate of origin, batch certificate of analysis, batch-release document, manufacturing and expiry dates, approved product information, and applicable GMP evidence.
  • State the labelled storage temperature and humidity limits, transport monitoring, shipping lane, and action for temperature excursion or damaged seals.
  • Define delivery to an authorised medicine warehouse, documented receipt, batch traceability, and FEFO distribution. Keep dispensing and interaction decisions with the treating clinician, not the export catalogue.

Frequently asked questions

  • What should you verify before comparing Abirakast 250 offers?

    Confirm that the product is registered as immediate-release abiraterone acetate 250 mg tablets. Request the exact manufacturer, marketing authorisation number, active-ingredient salt, dosage form and approved product information.

  • When do Abirakast 250 tablets fit a treatment plan?

    They fit only when the prescriber has selected abiraterone acetate 250 mg tablets for the patient and the prescribed administration and safety conditions are met. Do not substitute another strength, dosage form or abiraterone product without clinical approval.

  • How can you test an abiraterone exporter before requesting bulk supply?

    Ask for the exporter’s legal company details, manufacturing source, licence information, product authorisation, batch documents, expiry data, storage conditions and samples of shipping paperwork. Check that the documents identify the same product and manufacturer.

  • What must an export order specify for delivery to Tanzania or another market?

    State the product name, active ingredient and salt, 250 mg strength, immediate-release tablet form, pack size, quantity, batch and expiry requirements, storage conditions, destination, delivery terms and required regulatory and customs documents.

 2026-10-15T12:00:15

Keywords